On June 29, JD Health rose 3.25% in regular trading, trading at HK$33.04/share, with turnover of approximately HK$62 million.

The move was driven by a broad-based rebound across the Internet and Direct Marketing Retail sector. Among peers, Alibaba-W gained 4.41%, Meituan-W surged 5.68%, JD Group-SW rose 3.75%, Ali Health climbed 3.91%, and Ping An Good Doctor advanced 5.93%, reflecting collective sector recovery after recent weakness.

Additionally, JD Health has maintained a high-frequency share buyback cadence, repurchasing 500,000 shares daily for four consecutive trading days since June 22. Year-to-date, the company has cumulatively repurchased over 20.44 million shares, spending approximately HK$803 million. The buyback authorization, approved on June 20 of the prior year, permits repurchases of up to 320 million shares. As of June 26, approximately 20.94 million shares had been repurchased under this mandate, representing about 0.654% of issued share capital at the authorization date.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)